8-K
Current Report
Summit Therapeutics Inc. Filed Acc 0001193125-24-152292
Regulation FD disclosure · Other events
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d38200d8k.htm…